Author

Ankita Singh

Institute of Genomics and Integrative Biology

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Biology Disciplines

Click to filter author papers

Biophysics· 1 Cancer Biology· 1 Genetic & Genomic Medicine· 1 Immunology· 1 Molecular Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 5 Research Focus:differential expression· 3 Research Focus:gene regulatory network inference· 3 Approach:statistical model· 3 Assay:bulk RNA-seq· 2 Approach:experimental assay· 2 Assay:proteomics· 2 Research Focus:variant calling· 2

Frequent Co-Authors

Shantanu ChowdhuryiD· 2 shared Advaiti Pai Kane· 1 shared Amanda NewmaniD· 1 shared Ananda Kishore Mukherjee· 1 shared Anirban Kar· 1 shared Anurag MehtaiD· 1 shared Arnab GhoshiD· 1 shared Aruna KorlimarlaiD· 1 shared

Activity by Year

2016-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 17 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersGenetic & Genomic Medicine

Shantanu ChowdhuryORCID

Mutual co-authors in cluster

Author profile →

5 papers

Recent·Most cited

B Cell Receptor Signaling Sets Boundaries for Selection of Broadly Neutralizing Antibody Functional Mutations

Ankita Singh, Kara M. Anasti, Elizabeth S. Van Itallie, Amanda Newman, Advaiti Pai Kane, Maggie Barr, Robert Parks, Sravani Venkatayogi, Ming Tian, Kevin O. Saunders, Rory C. Henderson, Derek W. Cain, Frederick W. Alt, Barton F. Haynes, Laurent K. Verkoczy, , S. Munir Alam

The paper shows that B cell receptor signaling sets limits on the selection of functional mutations in antibodies, with mid-affinity antigens showing optimal neutralization.

bioRxiv · Aug 19, 2026 · PreprintImmunology

Whole-Genome Landscape of Breast Cancers from India shows Distinct Clinically Actionable Subtypes

Divya Khanna, Arnab Ghosh, Priyanka Bhadwal, Ramakanth Chirravuri-Venkata, Leepakshi Dhingra, Subrata Das, Isha Choubey, Ankita Singh, Geeta Jadaun, Hriday Home Chowdhury, Vibha Mattoo, Pooja Dixit, Suryanshi Tiwari, Safeer Khan, Vinit Gupta, , Shantanu Chowdhury

This study presents whole-genome and transcriptome analyses of breast tumors from India, identifying novel mutations, copy number alterations, and subtypes with clinical implications.

medRxiv · Mar 30, 2026 · PreprintGenetic & Genomic Medicine

The Indian Cancer Genome Atlas:A Multi-Omics Resource for Advancing Cancer Research

Suveera Dhup, Ankita Singh

The paper presents a multi-omic resource for Indian breast cancer patients, identifying genetic and proteomic alterations and immune-related gene expression patterns.

bioRxiv · Mar 25, 2025 · PreprintCancer Biology

Impedance-based assay for pan-cancer early and rapid detection of cell-free DNA

Tejal Dube, Puja Prasad, Pragya Swami, Ankita Singh, Meenakshi Verma, Parul Tanwar, Shantanu Chowdhury, Shalini Gupta

This paper introduces an impedance-based biosensor for rapid, label-free detection of cancer-associated cfDNA with high sensitivity and specificity across multiple cancer types.

bioRxiv · May 10, 2024 · PreprintBiophysics

Transcriptional activity of TRF2 is telomere length dependent

Ananda Kishore Mukherjee, Shalu Sharma, Parashar Dhapola, Dhurjhoti Saha, Tabish Hussain, Sumitabho Deb Roy, Gunjan Purohit, Anirban Kar, Ankita Singh, Suman Sengupta, Vivek Srivastava, Manish Kumar, Sagar Sengupta, Shantanu Chowdhury

The paper shows that longer telomeres reduce TRF2's extra-telomeric occupancy, including at the p21 promoter, making TRF2 a telomere-length-dependent repressor of p21.

bioRxiv · Jun 3, 2016 · PreprintMolecular Biology